Who makes Penicillin test and challenge?

Penicillin test and challenge is developed by Meir Medical Center.

What development phase is Penicillin test and challenge in?

Penicillin test and challenge is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Penicillin test and challenge

Meir Medical Center · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	Penicillin test and challenge
Sponsor	Meir Medical Center
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing (PHASE2)
Risk-stratified Testing for Safe Removal of Penicillin Allergy Labels (NA)
The Effect of Providing Stratification of Low Risk Penicillin Allergies on Penicillin Allergy Label Removal (NA)
Allergy Antibiotics And Microbial Resistance (NA)
Penicillin Allergy Delabeling Project (NA)
Penicillin Allergy Testing in STD Clinics (PHASE4)
Inpatient Penicillin Allergy Delabeling Study (PHASE4)
The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Penicillin test and challenge CI brief — competitive landscape report
Penicillin test and challenge updates RSS · CI watch RSS
Meir Medical Center portfolio CI